Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

336
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
336
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

341
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
341
Actuarial Approach01:20

Actuarial Approach

147
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
147
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

173
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
173
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

296
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
296
Censoring Survival Data01:09

Censoring Survival Data

274
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
274

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo fast motion computation in the primate visual cortex.

Cell reports·2026
Same author

Characterizing the frequency of clinical events and assessing biomarkers in propionic acidemia: a natural history study.

Orphanet journal of rare diseases·2026
Same author

Characteristics of cross-modal negative BOLD responses in the human sensory subcortex and cortex.

Journal of neurophysiology·2026
Same author

Determining the optimal radiation dose for locally advanced esophageal cancer: A pooled analysis of reconstructed individual patient data from randomized clinical trials.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors.

Pharmaceutical statistics·2024
Same author

Leveraging real-world data to conduct externally controlled trial for rare diseases with count-type endpoints: utilizing multiple entries - a simulation study.

Journal of biopharmaceutical statistics·2024
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Oct 9, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Estimating the treatment effect for adherers using multiple imputation.

Junxiang Luo1, Stephen J Ruberg2, Yongming Qu3

  • 1Department of Biostatistics and Programming, Moderna, Inc., Cambridge, Massachusetts, USA.

Pharmaceutical Statistics
|December 20, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a simpler method using multiple imputation (MI) and bootstrapping to estimate treatment effects in clinical trials, specifically for patients who adhere to treatment. The new approach provides consistent results and reliable confidence intervals for the adherent average causal effect (AdACE).

Keywords:
adherer average causal effectcounterfactual effectprincipal stratumtripartite estimands

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

791
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.7K

Related Experiment Videos

Last Updated: Oct 9, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

791
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.7K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Causal Inference

Background:

  • Randomized controlled trials (RCTs) are crucial for evaluating treatment efficacy and safety.
  • International Council on Harmonization (ICH)-E9 (R1) emphasizes considering intercurrent events (ICEs) when defining treatment effect estimands.
  • Principal stratum is a key strategy for handling ICEs, but existing methods for AdACE estimation are computationally complex.

Purpose of the Study:

  • To implement and evaluate a novel methodology for estimating the AdACE using multiple imputation (MI) and bootstrapping.
  • To provide a more accessible computational approach for AdACE estimation compared to existing high-dimensional integration methods.
  • To assess the performance of MI-based AdACE estimators through simulation studies.

Main Methods:

  • Utilized multiple imputation (MI) to handle missing data and intercurrent events.
  • Employed bootstrapping techniques to construct confidence intervals (CIs) for the AdACE.
  • Conducted a simulation study to evaluate the consistency and coverage probabilities of the proposed estimators.

Main Results:

  • The MI-based AdACE estimators demonstrated consistency.
  • Confidence intervals constructed through bootstrapping achieved nominal coverage probabilities.
  • The proposed method was successfully applied to a real-world clinical trial dataset.

Conclusions:

  • Multiple imputation combined with bootstrapping offers a practical and statistically sound approach for estimating the adherent average causal effect (AdACE).
  • This method simplifies the estimation of treatment effects for adherent populations, addressing limitations of previous complex computational techniques.
  • The findings support the use of this MI-based approach in clinical trial analysis, particularly for understanding treatment effects in the presence of intercurrent events.